Aspire Private Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-91
Closed -$1.74K 478
2024
Q3
$1.74K Hold
91
﹤0.01% 558
2024
Q2
$1.88K Hold
91
﹤0.01% 559
2024
Q1
$1.71K Sell
91
-72
-44% -$1.24K ﹤0.01% 592
2023
Q4
$2.35K Sell
163
-5
-3% -$68 ﹤0.01% 551
2023
Q3
$2.92K Sell
168
-1
-0.6% -$21 ﹤0.01% 529
2023
Q2
$3.52K Sell
169
-7
-4% -$152 ﹤0.01% 492
2023
Q1
$4.14K Sell
176
-23
-12% -$618 ﹤0.01% 466
2022
Q4
$5.55K Sell
199
-33
-14% -$844 ﹤0.01% 419
2022
Q3
$5K Sell
232
-5
-2% -$151 ﹤0.01% 419
2022
Q2
$8K Sell
237
-1
-0.4% -$35 ﹤0.01% 361
2022
Q1
$8K Sell
238
-27
-10% -$923 ﹤0.01% 355
2021
Q4
$8K Buy
265
+53
+25% +$1.73K ﹤0.01% 359
2021
Q3
$7K Buy
212
+12
+6% +$384 ﹤0.01% 342
2021
Q2
$6K Buy
+200
New +$6.58K ﹤0.01% 372

Other funds holding OGN

Aspire Private Capital's OGN Position: Q4 2024 in Review

Aspire Private Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 91 shares — an estimated $1.74K sold.

Aspire Private Capital first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $8K in Q2 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Aspire Private Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 91 Organon & Co shares in Q4 2024, an estimated $1.74K.
  • Aspire Private Capital first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • Aspire Private Capital's Organon & Co position peaked at $8K in Q2 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.